Department of Periodontology, University of Florida College of Dentistry, PO Box 100434, Gainesville, FL 32610-0434, USA.
J Dent Res. 2011 Sep;90(9):1140-4. doi: 10.1177/0022034511413928. Epub 2011 Jul 5.
While much research has focused on local and systemic factors contributing to periodontal disease, little is known regarding mechanisms linking these factors. We have previously reported a systemic hyper-inflammatory response to bacterial endotoxin in localized aggressive periodontitis (LAP). The objectives of this study were to delineate cyto/chemokines in gingival crevicular fluid (GCF) and evaluate systemic levels of endotoxin associated with LAP. Clinical parameters, GCF, and peripheral blood were collected from: 34 LAP, 10 healthy siblings, and nine healthy unrelated control individuals. Cyto/chemokines were quantified in GCF, systemic endotoxin levels were quantified in plasma, and correlation analysis was performed among all parameters. Nine mediators were elevated in LAP diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01). Four- to five-fold-higher endotoxin levels were detected in LAP plasma compared with that from healthy participants (p < 0.0001), which correlated with all clinical parameters and most cyto/chemokines analyzed. In conclusion, higher systemic levels of endotoxin were found in LAP, which correlates with an exacerbated local inflammatory response and clinical signs of disease. (Clinicaltrials.gov number, NCT01330719).
虽然许多研究都集中在导致牙周病的局部和全身因素上,但对于将这些因素联系起来的机制知之甚少。我们之前曾报道过局部侵袭性牙周炎(LAP)中细菌内毒素引起的全身炎症反应过度。本研究的目的是描述龈沟液(GCF)中的细胞因子/趋化因子,并评估与 LAP 相关的内毒素的全身水平。从 34 名 LAP 患者、10 名健康兄弟姐妹和 9 名健康无关对照个体中收集临床参数、GCF 和外周血。在 GCF 中定量细胞因子/趋化因子,在血浆中定量系统内毒素水平,并对所有参数进行相关性分析。与健康部位相比,LAP 患病部位有 9 种介质升高(TNFα、INFγ、IL1β、IL2、IL6、IL10、Il12p40、GMCSF 和 MIP1α,p < 0.001),而健康部位的 MCP1、IL4 和 IL8 升高(p < 0.01)。与健康参与者相比,LAP 血浆中的内毒素水平高出四到五倍(p < 0.0001),与所有临床参数和大多数分析的细胞因子/趋化因子相关。总之,在 LAP 中发现了更高的全身内毒素水平,这与局部炎症反应过度和疾病的临床体征相关。(临床试验注册号,NCT01330719)。